August 2019

Email is not displaying correctly? View it in your browser.  
 
 
August 09, 2019
 
 
 

Aflac Cancer Center Ranks Among Top 10 Pediatric Cancer Centers in U.S.

The Aflac Cancer and Blood Disorders Center ranked No. 8 in the nation for pediatric cancer care by U.S. News & World Report. "We are extremely proud to be recognized among the top pediatric cancer programs in the country, and this top ranking is a reflection of the dedication of our faculty, nurses and staff," said Douglas K. Graham, MD, PhD, Director, Aflac Cancer and Blood Disorders Center." In 2018, we had a record-breaking year in extramural funding, which is just one of many ways we continue to support our mission as a cancer and blood disorders center committed to exceptional patient care, innovation and research."
Learn more
 
 
 
     
 
 
Matthew's Wish: To Help His Doctor Help Other Children
Aflac Cancer Center patient, Matthew Gould, donated his Make-a-Wish to Dr. Ryan Summers to support his pediatric cancer research. This incredible story was covered by 11Alive.
Watch video
 
  
Katharine Brock Recognized as Outstanding Educator
Dr. Brock was recognized at Emory's 2019 Annual Educator Appreciation Day for her passion and skills to educate, encourage and support scholars and learners across Emory.
Read more
 
 
 
     
 
 
A New Way to Treat Hemophilia Patients
Our Hemostasis and Thrombosis team has developed a new way to treat pediatric hemophilia A patients with inhibitors. Immune tolerance induction (ITI) while on emicizumab prophylaxis is a feasible approach in pediatric hemophilia A patients with inhibitors. This is the first report of the concomitant use of ITI in patients receiving emicizumab prophylaxis described as the 'Atlanta Protocol'.
Read more
 
  
Christopher Porter Receives St. Baldrick's Consortium Research Grant
Dr. Porter received a $250K grant to create a Consortium for Childhood Cancer Predisposition focused on improving outcomes for those at the highest risk of cancer through better identification, early tumor detection, optimized psychosocial support and cancer prevention. The Consortium will initially be comprised of seven institutions and led by individuals who have previously worked together to have significant impacts in this field. These individuals will engage syndrome-specific advocacy groups to accelerate patient-centered advances.
 
 
 

More than $1.7M Raised During Annual WSB Care-a-Thon

The 19th Annual WSB Care-a-Thon was held July 25 and July 26. After a successful 37 hours, and thanks to amazing donors, we continued to collect donations and exceeded $1.7 million in donations this year. Money raised from this two-day event supports research, the Fellowship Program and the Family Support Team. In total, the WSB Care-a-Thon has raised more than $24M for the Aflac Cancer and Blood Disorders Center. Thank you to everyone who made this possible!
Read more
 
 
 
     
 
 
Aflac Cancer Center Physicians Featured in Atlanta Magazine's 2019 Top Doctors
Atlanta Magazine announced the 2019 Top Doctors in Atlanta, and eight of our physicians were recognized with this honor in the Pediatric Hematology/Oncology section: Drs. Michael Briones, Sharon Castellino, Beatrice Gee, Frank Keller, Glen Lew, Tobey MacDonald, Lillian Meacham and Thomas Olson.
Read more
 
  
CURE Childhood Cancer Funds Aflac Investigators
The Aflac Cancer and Blood Disorders Center was recently awarded more than $3M by CURE Childhood Cancer to fund individual research projects, the Fellowship and the Precision Medicine Programs. With this year's commitment, CURE has given more than $22M to the Aflac Cancer Center in the past 11 years.
Read more
 
 
 
     
 
 
NEW! Donaldson Trust Synergy Fund to Support Collaborative Cancer Research
Aflac Cancer and Blood Disorders Center in collaboration with Winship Cancer Institute and the Wallace H. Coulter Biomedical Engineering Department at Emory University and the Georgia Institute of Technology has created a 2019 Pilot Grant supported by The Donaldson Charitable Trust Research Synergy Fund. As a result of a generous donation from the Oliver S. and Jennie R. Donaldson Charitable Trust, we are pleased to announce this peer-reviewed program to provide pilot funding for novel, innovative, and collaborative cancer research projects.
Apply today
 
  
Welcome New Faculty!
Please join us in welcoming the newest additions to the Aflac Cancer and Blood Disorders Center: Xu Ji, PhD, MSPH, Assistant Professor and our center's first Health Services Researcher; and Waitman Aumann, MD, Assistant Professor.
 
 
 

 
 
 

Berg CJ, Vanderpool RC, Getachew B, Payne JB, Johnson MF, Sandridge Y, Bierhoff J, Le L, Johnson R, Weber A, Patterson A, Dorvil S, Mertens A
"A Hope-Based Intervention to Address Disrupted Goal Pursuits and Quality of Life Among Young Adult Cancer Survivors." - Journal of Cancer Education
 
 
 

Brousseau DC, Richardson T, Hall M, Ellison AM, Shah SS, Raphael JL, Bundy DG, Arnold S
"Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children." - Pediatrics
 
 
 

Castellino SM, Allen KE, Pleasant K, Keyes G, Poehling KA, Tooze JA
"Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer." - Journal of Cancer Survivorship
 
 
 

Chonat S, Risinger M, Sakthivel H, Niss O, Rothman JA, Hsieh L, Chou ST, Kwiatkowski JL, Khandros E, Gorman MF, Wells DT, Maghathe T, Dagaonkar N, Seu KG, Zhang K, Zhang W, Kalfa TA
"The Spectrum of SPTA1-Associated Hereditary Spherocytosis." - Frontiers in Physiology
 
 
 

Di Paola J, Porter CC
"ETV6-Related Thrombocytopenia and Leukemia Predisposition. " - Blood Journal
 
 
 

Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M
"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial." - Lancet Oncology
 
 
 

Field JJ, Ballas SK, Campbell CM, Crosby LE, Dampier C, Darbari DS, McClish DK, Smith WR, Zempsky WT
"AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain." - Journal of Pain
 
 
 

Meeks SL and Herzog RW
"The national blueprint for future basic and translational research to understand the factor VIII immunogenicity: NHLBI State of the Science Workshop on factor VIII inhibitors." - Haemophilia
 
 
 

Maximov V, Chen Z, Wei Y, Robinson MH, Herting CJ, Shanmugam NS, Rudneva VA, Goldsmith KC, MacDonald TJ, Northcott PA, Hambardzumyan D, Kenney AM
"Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma." - Nature Communications
 
 
 

Quach ME, Syed AK, Li R
"A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry." - Journal of Visualized Experiments
 
 
 

Tang A, Branscomb J, Zhou M, Snyder A, Eckman J
"Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease." - Pediatric Blood & Cancer
 
 
 

 
 
 

View Fundraising Events

 
 
 

E-store

 
 
 
 
  
 
 

Emory Home | CHOA Newsroom | Join the Fight | Contact Us
Have a story for Aflac Report? Submit your suggestion via email.